Clinical Trial Update: Safety, Performance of CEREGLIDE 92 Intermediate Catheter in Treatment of Acute Ischemic Stroke [NA]

View source ↗

Summary

The clinical trial evaluating the CEREGLIDE 92 Intermediate Catheter for acute ischemic stroke has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• CEREGLIDE 92 Intermediate Catheter

Snippet

Sponsor: Cerenovus, Part of DePuy Synthes Products, Inc. | Conditions: Acute Ischemic Stroke | NA | Status: WITHDRAWN